GVB Biopharma Information

Get Verified Emails For GVB Biopharma
Contact top employees from GVB Biopharma

Summary

GVB Biopharma is a private company. The company currently specializes in the Biotechnology area. The GVB Biopharma annual revenue is estimated at < 1M. To connect with GVB Biopharma employee register on SignalHire.

Organization Website

gvbbiopharma.com

Social Links

facebooklinkedIntwitter

Phone Number

+2139261580

Industries

Headquarters Location

4456 E Craig Rd, Las Vegas, Nevada, 89115 US

Employees Size

100-200 employees

Specialties

Formulation

Operating Status

Independent Company

Competitors

Founded
Type
Employees
Revenue
Funding
2003Public
Company
250 - 500 101.1M $165.4M
2008Privately
Held
1 - 25 < 1M $82.5M
1994Public
Company
200-500 - $-

Employees Turnover 4 quarter 2025

Length of Employment
arrow
Employee tenure at GVB Biopharma shows a diverse range of experience levels:
11% for 1–2 years17% for 3–4 years50% for 5–7 years17% for 8–10 years6% have over 11 years of service at GVB Biopharma
Discover More
Ex-employees positions
In Company
In New Company
Sign Up
Contact top employees from GVB Biopharma

FAQ

GVB Biopharma operates in the Biotech industries. More details can be found on the official website: gvbbiopharma.com.
The headquarters of GVB Biopharma are located in Las Vegas, United States.
You can contact GVB Biopharma by phone at +2139261580.
GVB Biopharma currently employs 100-200 people.
GVB Biopharma's revenue is approximately < 1M.
Well-known competitors of GVB Biopharma include Acceleron Pharma, Immunome, Inc. and Agenus.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP